Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...

Women are more than twice as likely to develop post-traumatic stress disorder than men, and a new study demonstrates for the ...

Spending reached $4.86 trillion in 2023, a 7.5% increase from 2022 The growth in spending on hospital care was the highest since 1990.

The FDA has approved Celltrion’s Stelara biosimilar Steqeyma (CT-P43), for adult and pediatric patients with plaque psoriasis ...

A pooled analysis of two prior trials suggests patients with a variety of cardiac index scores saw improvement when Winrevair ...

A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...

If approved, clesrovimab would be the first and only FDA approved single dose immunization for infants approved in time for ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

The FDA approved Vtama (tapinarof) cream 1% for treating atopic dermatitis (AD) in adults and children as young as ...

Previous studies have found no association between vaccination and MS in adults. To evaluate the association between ...

The combination of Spinraza and Zolgensma could improve clinical outcomes in infants with spinal muscular atrophy without ...